Bio-Works presents Q3 2026 with strong order intake
Order intake increased to SEK 40.8 million while Eva Lindskog was appointed new CEO.
See the latest news and media coverage for Bio-Works. We track all announcements, press releases, and industry mentions in real time, all in one place.
Manufacturer of chromatography resins for biopharmaceutical purification
bio-works.comLast updated
In short: Bio-Works posted mixed quarterly sales, won large orders and announced a CEO transition in 2026.
Order intake increased to SEK 40.8 million while Eva Lindskog was appointed new CEO.
Net sales fell to 9.7 MSEK while order intake surged to 40.8 MSEK, supporting the existing order book of 38.1 MSEK as the company highlights its growth phase performance.
Sales increased to 20.0 MSEK. Order intake was lower by 8.9 MSEK.
Operating result improves and CEO leaves for Eva Lindskog who takes office in November.
Bio-Works reports an operating result of -8.1 million SEK for the third quarter of 2026 (-1.2). The article is part of our exclusive news service Marknadsnytt. You get...
Close LIVE: Report Morning July 17. Bio-Works has received a new order from a recurring customer with an order value of SEK 22.6 million. SEHED Byggmästargruppen takes...
HOLMDEL, N.J., April 22, 2026 (GLOBE NEWSWIRE)-- BIO-key International, Inc. (Nasdaq: BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies...
TG4050 is an individualized immunotherapy based on an MVA viral vector incorporating neoantigens selected using NEC's AI-enabled prediction platform. It is currently being evaluated in...
Track Bio-Works and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Bio-Works and other trending companies.